Add BrightSurf on Google Email

Search results for “Pharmacology”

1,000+ results for "Pharmacology"

Could drugs replace gastric bypass surgery?

Researchers have identified B0AT1 inhibitors as a potential replacement for gastric bypass surgery in treating obesity and related disorders. These compounds, including benztropine, could replicate the effects of gastric bypass by reducing nutrient absorption, offering a new treatment option.

SourceWiley·JournalBritish Journal of Pharmacology·DateFeb 8, 2017

Risk of liver cancer is low in patients with cirrhosis

A recent study published in Alimentary Pharmacology & Therapeutics found that the 10-year incidence of liver cancer in UK patients with cirrhosis is as low as 4%. Patients with cirrhosis due to chronic viral hepatitis have the highest risk, but even then, it's lower than expected.

SourceWiley·JournalAlimentary Pharmacology & Therapeutics·DateFeb 1, 2017

Making medications safer for newborns

Researchers are working to develop safer drug treatments for newborns through increased clinical trials and improved efficiency. Currently, most medication treatments in newborns are based on adult studies, which can lead to uncertainty about their effectiveness.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateOct 4, 2016

Adverse drug reactions may be under-reported in young children

A new study reveals that spontaneous reports of adverse drug reactions in newborns and infants are insufficient, highlighting the need for additional reporting strategies. The UK's Yellow Card Scheme, established over 50 years ago, has improved drug safety but may not be enough to capture all instances of adverse reactions.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateSep 7, 2016

Many physicians still prescribe controversial drug combination

A significant number of patients on clopidogrel therapy are also prescribed proton pump inhibitors (PPIs) omeprazole or esomeprazole, increasing the risk of cardiovascular events. Despite regulatory warnings, many physicians have continued to prescribe this combination.

SourceWiley·JournalPharmacology Research & Perspectives·DateAug 2, 2016

New lipid-lowering drugs help patients reduce LDL cholesterol

Researchers found that adding anti-PCSK9 antibodies to existing treatments can significantly reduce LDL cholesterol levels in patients. The studies demonstrated a reduction in LDL cholesterol and achieved high response rates for both alirocumab and evolocumab.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateAug 1, 2016

Risk of low blood sugar differs among similar diabetes drugs

A new systematic review found that gliclazide confers the lowest risk of hypoglycemia when added to metformin. This suggests prescribing a medication with a lower risk of low blood sugar may be a rational and affordable alternative for patients with type 2 diabetes.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateJul 19, 2016

Beware of antioxidants, warns scientific review

Antioxidant supplements have been linked to cardiovascular disease, cancer, diabetes, and other conditions due to their impact on oxygen radicals. However, the review suggests that targeting specific sources of oxygen molecules may be a more effective approach.

SourceWiley·JournalBritish Journal of Pharmacology·DateJul 19, 2016

Evolution meets biochemistry to better understand how dopamine receptors work

Baylor College of Medicine researchers have developed a new mathematical tool that combines biochemistry and computational analysis to identify specific structural changes in the dopamine 2 receptor, which helps maintain its structure and function throughout an evolutionary time scale. This discovery opens the possibility for better dr...

SourceBaylor College of Medicine·JournalProceedings of the National Academy of Sciences·DateMar 16, 2016

Spider toxin analogue may help relieve pain

A spider toxin analogue, PnPP-19, has shown promise in relieving pain by targeting nervous system receptors similar to opioids and cannabis. The compound is also being studied for erectile dysfunction treatment.

SourceWiley·JournalBritish Journal of Pharmacology·DateMar 7, 2016

Heart arrhythmia drug may fight plaque buildup in blood vessels

Researchers found that digoxin decreased levels of total cholesterol and triglycerides by 41% and 54%, respectively, in mice treated with high-dose digoxin. Digoxin also lowered LDL-cholesterol levels by 20%. The study suggests a potential link between the drug and reduced plaque buildup.

SourceWiley·JournalBritish Journal of Pharmacology·DateFeb 16, 2016

Cancer drug helps combat asthma in mice

Dasatinib, a cancer treatment, reduces inflammation and improves lung mechanics in mice with allergic asthma. The drug targets tyrosine kinases involved in asthma's signaling pathways.

SourceWiley·JournalBritish Journal of Pharmacology·DateFeb 1, 2016

New guide highlights the properties of diverse drug targets

The Concise Guide to PHARMACOLOGY 2015/2016 provides an overview of 1,700 human drug targets, focusing on those exploited in the clinic or with future therapeutic potential. The guide combines evidence-based data with summaries of molecular targets, allowing users to rapidly gain insight into their function and comparative pharmacology.

SourceWiley·JournalBritish Journal of Pharmacology·DateJan 4, 2016